Bio-S

Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (hereinafter referred to as "Bio-Sincerity Pharma") was established in 2011. It is a comprehensive pharmaceutical technology research and development enterprise focusing on pharmaceutical research. The company adopts a dual-line development strategy of "contracted R&D services + R&D technology achievement transformation," mainly providing drug R&D services and R&D technology achievement transformation for various pharmaceutical enterprises and pharmaceutical R&D investment companies. The company's business covers key aspects of drug discovery, pharmaceutical research, clinical research, registration applications, and other major stages of drug development. It has core competitive advantages in pharmaceutical research and bioequivalence testing (referred to as BE clinical trials). While strengthening its competitive advantage in contracted R&D services, the company is committed to taking the initiative to lead the development path of pharmaceutical technology R&D, continuously increasing investment in independent R&D to achieve product development leadership and proactively promoting the transformation of R&D technology achievements, sharing and integrating with partners.Since its establishment, the company has highly valued the construction of R&D platforms, establishing laboratories covering an area of more than 18,000 square meters, equipped with hundreds of types of equipment and instruments. Based on years of accumulation and R&D investment, the company has built platforms for innovative drug R&D, generic drugs and consistency evaluation pharmaceutical research, BE/PK research, packaging compatibility research, etc. It has deeply laid out in high-end formulation fields such as inhalation preparations, transdermal preparations, controlled-release preparations, and fine granules, forming strong core competitive advantages. After years of development and accumulation, the company has gained widespread recognition and praise from customers in the industry and has become a pharmaceutical R&D enterprise with strong competitiveness in China. Based on its powerful R&D capabilities and abundant technical achievements, the company has been awarded honors such as a national "High-tech Enterprise," "Provincial High-tech Enterprise Research and Development Center," "Zhejiang Province High-growth Technology SME," and others.